IL17A and chronic obstructive pulmonary disease: In parallel, an upregulation of IL17 signaling pathway in mild, moderate and severe zones from COPD lungs is found in this study, confirming previous observations (36) supporting that IL17 plays a role in driving both innate and adaptive immune responses in COPD, and could represent a future therapeutic target (37).